1
|
Silva AI, Sønderby IE, Kirov G, Abdellaoui A, Agartz I, Ames D, Armstrong NJ, Artiges E, Banaschewski T, Bassett AS, Bearden CE, Blangero J, Boen R, Boomsma DI, Bülow R, Butcher NJ, Calhoun V, Campbell LE, Chow EWC, Ciufolini S, Craig MC, Crespo-Farroco B, Cunningham AC, Dalvie S, Daly E, Dazzan P, de Geus EJC, de Zubicaray GI, Doherty JL, Donohoe G, Drakesmith M, Espeseth T, Frouin V, Garavan H, Glahn DC, Goodrich-Hunsaker NJ, Gowland PA, Grabe HJ, Grigis A, Gudbrandsen M, Gutman BA, Haavik J, Håberg AK, Hall J, Heinz A, Hohmann S, Hottenga JJ, Jacquemont S, Jahanshad N, Jonas RK, Jones DK, Jönsson EG, Koops S, Kumar K, Le Hellard S, Lemaitre H, Liu J, Lundervold AJ, Martinot JL, Mather KA, McDonald-McGinn DM, McMahon KL, McRae AF, Medland SE, Moreau CA, Murphy KC, Murphy D, Murray RM, Nees F, Owen MJ, Paillère Martinot ML, Orfanos DP, Paus T, Poustka L, Marques TR, Roalf DR, Sachdev PS, Scheffler F, Schmitt JE, Schumann G, Steen VM, Stein DJ, Strike LT, Teumer A, Thalamuthu A, Thomopoulos SI, Tordesillas-Gutiérrez D, Trollor JN, Uhlmann A, Vajdi A, Ent DV', van Amelsvoort T, van den Bree MBM, van der Meer D, Vázquez-Bourgon J, Villalón-Reina JE, Völker U, Völzke H, Vorstman JAS, Westlye LT, et alSilva AI, Sønderby IE, Kirov G, Abdellaoui A, Agartz I, Ames D, Armstrong NJ, Artiges E, Banaschewski T, Bassett AS, Bearden CE, Blangero J, Boen R, Boomsma DI, Bülow R, Butcher NJ, Calhoun V, Campbell LE, Chow EWC, Ciufolini S, Craig MC, Crespo-Farroco B, Cunningham AC, Dalvie S, Daly E, Dazzan P, de Geus EJC, de Zubicaray GI, Doherty JL, Donohoe G, Drakesmith M, Espeseth T, Frouin V, Garavan H, Glahn DC, Goodrich-Hunsaker NJ, Gowland PA, Grabe HJ, Grigis A, Gudbrandsen M, Gutman BA, Haavik J, Håberg AK, Hall J, Heinz A, Hohmann S, Hottenga JJ, Jacquemont S, Jahanshad N, Jonas RK, Jones DK, Jönsson EG, Koops S, Kumar K, Le Hellard S, Lemaitre H, Liu J, Lundervold AJ, Martinot JL, Mather KA, McDonald-McGinn DM, McMahon KL, McRae AF, Medland SE, Moreau CA, Murphy KC, Murphy D, Murray RM, Nees F, Owen MJ, Paillère Martinot ML, Orfanos DP, Paus T, Poustka L, Marques TR, Roalf DR, Sachdev PS, Scheffler F, Schmitt JE, Schumann G, Steen VM, Stein DJ, Strike LT, Teumer A, Thalamuthu A, Thomopoulos SI, Tordesillas-Gutiérrez D, Trollor JN, Uhlmann A, Vajdi A, Ent DV', van Amelsvoort T, van den Bree MBM, van der Meer D, Vázquez-Bourgon J, Villalón-Reina JE, Völker U, Völzke H, Vorstman JAS, Westlye LT, Williams N, Wittfeld K, Wright MJ, Thompson PM, Andreassen OA, Linden DEJ, ENIGMA-CNV working group. Penetrance of neurodevelopmental copy number variants is associated with variations in cortical morphology. BIOLOGICAL PSYCHIATRY. COGNITIVE NEUROSCIENCE AND NEUROIMAGING 2025:S2451-9022(25)00169-7. [PMID: 40414598 DOI: 10.1016/j.bpsc.2025.05.010] [Show More Authors] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2025] [Revised: 05/07/2025] [Accepted: 05/19/2025] [Indexed: 05/27/2025]
Abstract
BACKGROUND Copy number variants (CNVs) increase risk for neurodevelopmental conditions. The neurobiological mechanisms linking these high-risk genetic variants to clinical phenotypes are largely unknown. An important question is whether brain abnormalities in individuals carrying CNVs are associated with their degree of penetrance. METHODS We investigated if increased CNV-penetrance for schizophrenia and other developmental disorders was associated with variations in cortical and subcortical morphology. We pooled T1-weighted brain magnetic resonance imaging and genetic data from 22 cohorts from the ENIGMA-CNV consortium. In the main analyses, we included 9,268 individuals (aged 7 to 90 years, 54% females), from which we identified 398 carriers of 36 neurodevelopmental CNVs at 20 distinct loci. A secondary analysis was performed including additional neuroimaging data from the ENIGMA-22q consortium, including 274 carriers of the 22q11.2 deletion and 291 non-carriers. CNV-penetrance was estimated through penetrance scores that were previously generated from large cohorts of patients and controls. These scores represent the probability risk to develop either schizophrenia or other developmental disorders (including developmental delay, autism spectrum disorder and congenital malformations). RESULTS For both schizophrenia and developmental disorders, increased penetrance scores were associated with lower surface area in the cerebral cortex and lower intracranial volume. For both conditions, associations between CNV-penetrance scores and cortical surface area were strongest in regions of the occipital lobes, specifically in the cuneus and lingual gyrus. CONCLUSIONS Our findings link global and regional cortical morphometric features with CNV-penetrance, providing new insights into neurobiological mechanisms of genetic risk for schizophrenia and other developmental disorders.
Collapse
Affiliation(s)
- Ana I Silva
- School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands; Neuroscience and Mental Health Innovation Institute, Cardiff University, Cardiff, United Kingdom; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA.
| | - Ida E Sønderby
- Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway; KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway
| | - George Kirov
- Neuroscience and Mental Health Innovation Institute, Cardiff University, Cardiff, United Kingdom; Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom; Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom
| | - Abdel Abdellaoui
- Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
| | - Ingrid Agartz
- Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden; Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway
| | - David Ames
- University of Melbourne Academic Unit for Psychiatry of Old Age, Kew, Victoria, Australia
| | | | - Eric Artiges
- Institut National de la Santé et de la Recherche Médicale, INSERM U1299 "Trajectoires développementales et psychiatrie", Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France; Psychiatry Department, EPS Barthélémy Durand, Etampes, Île-de-France, France
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
| | - Anne S Bassett
- Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Dalglish Family 22q Clinic for Adults with 22q11.2 Deletion Syndrome, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
| | - Carrie E Bearden
- Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA; Department of Psychology, University of California, Los Angeles, CA, USA
| | - John Blangero
- Department of Human Genetics and South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley, Brownsville, Texas, USA
| | - Rune Boen
- Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA
| | - Dorret I Boomsma
- Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, The Netherlands; Amsterdam Public Health Research Institute, Amsterdam UMC, the Netherlands
| | - Robin Bülow
- Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany
| | - Nancy J Butcher
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada
| | - Vince Calhoun
- Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State, Georgia Tech, Emory University, Atlanta, GA, USA
| | - Linda E Campbell
- School of Psychological Sciences, University of Newcastle, Newcastle, New South Wales, Australia
| | - Eva W C Chow
- Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
| | - Simone Ciufolini
- Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
| | - Michael C Craig
- National Female Hormone Clinic, London, United Kingdom; Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
| | - Benedicto Crespo-Farroco
- Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Sevilla, Spain; Instituto de Investigación Biomédica de Sevilla IBIS-CSIC, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Departamento de Psiquiatría, Sevilla, Spain
| | - Adam C Cunningham
- Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom; Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom
| | - Shareefa Dalvie
- Biomedical Research and Innovation Platform, South African Medical Research Council (SAMRC), Cape Town, South Africa; Department of Psychiatry & Neuroscience Institute, University of Cape Town, Cape Town, South Africa
| | - Eileen Daly
- Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
| | - Paola Dazzan
- Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
| | - Eco J C de Geus
- Department of Biological Psychology, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Amsterdam Public Health Research Institute, Amsterdam UMC, the Netherlands
| | - Greig I de Zubicaray
- School of Psychology and Counselling, Faculty of Health, Queensland University of Technology, Brisbane, Australia
| | - Joanne L Doherty
- Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom; Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom; Cardiff University's Brain Research Imaging Centre, School of Psychology, Cardiff University, Cardiff, United Kingdom
| | - Gary Donohoe
- School of Psychology, University of Galway, Galway, Ireland; Center for Neuroimaging, Cognition and Genomics, University of Galway, Galway, Ireland
| | - Mark Drakesmith
- Cardiff University's Brain Research Imaging Centre, School of Psychology, Cardiff University, Cardiff, United Kingdom; Communicable Disease Surveillance Centre, Public Health Wales, Cardiff, Wales, United Kingdom
| | - Thomas Espeseth
- Department of Psychology, University of Oslo, Oslo, Norway; Department of Psychology, Oslo New University College, Oslo, Norway
| | - Vincent Frouin
- Université Paris-Saclay, CEA, Neurospin, Gif-sur-Yvette, France
| | - Hugh Garavan
- Department of Psychological Science, University of Vermont, Burlington, Vermont, USA
| | - David C Glahn
- Department of Psychiatry and Behavioral Sciences, Boston Children's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
| | | | - Penny A Gowland
- Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom
| | - Hans J Grabe
- Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany
| | - Antoine Grigis
- Université Paris-Saclay, CEA, Neurospin, Gif-sur-Yvette, France
| | - Maria Gudbrandsen
- Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; Centre for Research in Psychological Wellbeing (CREW), School of Psychology, University of Roehampton, London, United Kingdom
| | - Boris A Gutman
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA
| | - Jan Haavik
- Department of Biomedicine, University of Bergen, Bergen, Norway; Division of Psychiatry, Haukeland University Hospital, Bergen, Norway
| | - Asta K Håberg
- Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; MiDT National Research Center, Centre for Medical Equipment, Technology, and Innovation, St. Olav's Hospital
| | - Jeremy Hall
- Neuroscience and Mental Health Innovation Institute, Cardiff University, Cardiff, United Kingdom; Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom; Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Center for Mental Health (DZPG), Partner Site Berlin-Potsdam, Berlin, Germany
| | - Sarah Hohmann
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Hamburg, Germany
| | - Jouke-Jan Hottenga
- Department of Biological Psychology, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Neurological Disorder Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation, Doha P.O. Box 5825, Qatar
| | - Sébastien Jacquemont
- Centre de recherche CHU Sainte Justine, Department of Psychiatry and Addictology, University of Montreal, Montreal, Quebec, Canada; Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
| | - Neda Jahanshad
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - Rachel K Jonas
- Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA
| | - Derek K Jones
- Cardiff University's Brain Research Imaging Centre, School of Psychology, Cardiff University, Cardiff, United Kingdom
| | - Erik G Jönsson
- Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden
| | - Sanne Koops
- Biomedical Sciences of Cells and Systems, University Medical Center Groningen, Rijksuniversiteit Groningen, Groningen, the Netherlands
| | - Kuldeep Kumar
- Centre de recherche CHU Sainte Justine, Department of Psychiatry and Addictology, University of Montreal, Montreal, Quebec, Canada
| | - Stephanie Le Hellard
- NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway; Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway
| | - Herve Lemaitre
- Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives, CNRS UMR 5293, Université de Bordeaux, Centre Broca Nouvelle-Aquitaine, Bordeaux, France
| | - Jingyu Liu
- Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State, Georgia Tech, Emory University, Atlanta, GA, USA; Department of Computer Science, Georgia State University, Atlanta, Georgia
| | - Astri J Lundervold
- Department of Biological and Medical Psychology, University of Bergen, Norway
| | - Jean-Luc Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM U1299 "Trajectoires développementales et psychiatrie", Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France
| | - Karen A Mather
- Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry & Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; Neuroscience Research Australia, Sydney, NSW, Australia
| | - Donna M McDonald-McGinn
- Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, USA; Division of Human Genetics, 22q and You Center, Clinical Genetics Center, Section of Genetic Counseling, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Human Biology and Medical Genetics, Sapienza University, Rome, Italy
| | - Katie L McMahon
- School of Clinical Sciences, Queensland University of Technology, Brisbane, Australia
| | - Allan F McRae
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia
| | - Sarah E Medland
- Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - Clara A Moreau
- Centre de recherche CHU Sainte Justine, Department of Psychiatry and Addictology, University of Montreal, Montreal, Quebec, Canada
| | - Kieran C Murphy
- Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - Declan Murphy
- Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
| | - Robin M Murray
- Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
| | - Frauke Nees
- Institute of Medical Psychology and Medical Sociology, University Medical Center Schleswig-Holstein, Kiel University, Kiel, Germany
| | - Michael J Owen
- Neuroscience and Mental Health Innovation Institute, Cardiff University, Cardiff, United Kingdom; Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom; Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom
| | - Marie-Laure Paillère Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM U1299 "Trajectoires développementales et psychiatrie", Université Paris-Saclay, Ecole Normale supérieure Paris-Saclay, CNRS, Centre Borelli, Gif-sur-Yvette, France; APHP.sorbonne Université, Child and adolescent psychiatry department, Pitié-salpêtrière hospital, Paris, France
| | | | - Tomas Paus
- Departments of Psychiatry and Neuroscience, Faculty of Medicine and Centre Hospitalier, Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada; Department of Psychiatry, McGill University, Montreal, Quebec, Canada
| | - Luise Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany
| | - Tiago Reis Marques
- Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom; Psychiatric Imaging Group, MRC London Institute of Medical Sciences (LMS), Hammersmith Hospital, Imperial College London, London, United Kingdom
| | - David R Roalf
- Neurodevelopment and Psychosis Section, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - Perminder S Sachdev
- Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry & Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, NSW, Australia
| | - Freda Scheffler
- Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, Western Cape, South Africa; Neuroscience Institute, University of Cape Town, Cape Town, Western Cape, South Africa
| | - J Eric Schmitt
- Neurodevelopment and Psychosis Section, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA; Department of Radiology, Division of Neuroradiology, University of Pennsylvania, Philadelphia, PA, USA
| | - Gunter Schumann
- Centre for Population Neuroscience and Stratified Medicine (PONS), ISTBI, Fudan University, Shanghai, P.R. China; PONS Centre, Department of Psychiatry and Clinical Neuroscience, Charite University Medicine, Berlin, Germany
| | - Vidar M Steen
- NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway; Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway
| | - Dan J Stein
- SAMRC Unit on Risk & Resilience, Dept of Psychiatry & Neuroscience Institute, University of Cape Town, Cape Town, South Africa
| | - Lachlan T Strike
- Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - Alexander Teumer
- Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany
| | - Anbupalam Thalamuthu
- Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry & Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia
| | - Sophia I Thomopoulos
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - Diana Tordesillas-Gutiérrez
- Instituto de Física de Cantabria (UC-CSIC), Santander, Spain; Department of Radiology, IDIVAL, Marqués de Valdecilla University Hospital, Santander, Spain
| | - Julian N Trollor
- Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry & Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia; National Centre of Excellence in Intellectual Disability Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia
| | - Anne Uhlmann
- Department of Child and Adolescent Psychiatry and Psychotherapy, TU Dresden, Dresden, Germany
| | - Ariana Vajdi
- Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA; Charles R. Drew University of Medicine and Science, Los Angeles, CA, USA
| | - Dennis van 't Ent
- Amsterdam Public Health Research Institute, Amsterdam UMC, the Netherlands; Department of Biological Psychology, Faculty of Behavioral and Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
| | - Therese van Amelsvoort
- School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
| | - Marianne B M van den Bree
- Neuroscience and Mental Health Innovation Institute, Cardiff University, Cardiff, United Kingdom; Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom; Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom
| | - Dennis van der Meer
- School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands; Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Javier Vázquez-Bourgon
- Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Sevilla, Spain; Department of Psychiatry, IDIVAL, University Hospital Marqués de Valdecilla, Santander, Spain; Departamento de Medicina y Psiquiatría, Universidad de Cantabria, Santander, Spain
| | - Julio E Villalón-Reina
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - Uwe Völker
- DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, Greifswald, Germany; Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Jacob A S Vorstman
- Department of Psychiatry, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada; Genetics and Genome Biology, SickKids Research Institute, Toronto, Ontario, Canada
| | - Lars T Westlye
- Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway; Department of Psychology, University of Oslo, Oslo, Norway
| | - Nigel Williams
- Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom; Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom
| | - Katharina Wittfeld
- Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany
| | - Margaret J Wright
- Queensland Brain Institute, The University of Queensland, Brisbane, Australia
| | - Paul M Thompson
- Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - Ole A Andreassen
- Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Section for Precision Psychiatry, Oslo University Hospital, Oslo, Norway
| | - David E J Linden
- School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
| | | |
Collapse
|
2
|
Karakuzu A, Blostein N, Caron AV, Boré A, Rheault F, Descoteaux M, Stikov N. Rethinking MRI as a measurement device through modular and portable pipelines. MAGMA (NEW YORK, N.Y.) 2025:10.1007/s10334-025-01245-3. [PMID: 40274699 DOI: 10.1007/s10334-025-01245-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/30/2024] [Revised: 02/27/2025] [Accepted: 03/11/2025] [Indexed: 04/26/2025]
Abstract
The premise of MRI as a reliable measurement device is limited by proprietary barriers and inconsistent implementations, which prevent the establishment of measurement uncertainties. As a result, biomedical studies that rely on these methods are plagued by systematic variance, undermining the perceived promise of quantitative imaging biomarkers (QIBs) and hindering their clinical translation. This review explores the added value of open-source measurement pipelines in minimizing variability sources that would otherwise remain unknown. First, we introduce a tiered benchmarking framework (from black-box to glass-box) that exposes how opacity at different workflow stages propagates measurement uncertainty. Second, we provide a concise glossary to promote consistent terminology for strategies that enhance reproducibility before acquisition or enable valid post-hoc pooling of QIBs. Building on this foundation, we present two illustrative measurement workflows that decouple workflow logic from the orchestration of computational processes in an MRI measurement pipeline, rooted in the core principles of modularity and portability. Designed as accessible entry points for implementation, these examples serve as practical guides, helping users adapt the frameworks to their specific needs and facilitating collaboration. Through critical evaluation of existing approaches, we discuss how standardized workflows can help identify outstanding challenges in translating glass-box frameworks into clinical scanner environments. Ultimately, achieving this goal will require coordinated efforts from QIB developers, regulators, industry partners, and clinicians alike.
Collapse
Affiliation(s)
- Agah Karakuzu
- NeuroPoly Lab, Polytechnique Montreal, Montreal, Québec, Canada
- Montreal Heart Institute, University of Montreal, Montreal, Québec, Canada
| | - Nadia Blostein
- School of Medicine, University Collage Cork, Cork, Ireland.
| | - Alex Valcourt Caron
- Sherbrooke Connectivity Imaging Laboratory (SCIL), Computer Science Department, Université de Sherbrooke, Sherbrooke, Québec, Canada
| | - Arnaud Boré
- Sherbrooke Connectivity Imaging Laboratory (SCIL), Computer Science Department, Université de Sherbrooke, Sherbrooke, Québec, Canada
| | - François Rheault
- Sherbrooke Connectivity Imaging Laboratory (SCIL), Computer Science Department, Université de Sherbrooke, Sherbrooke, Québec, Canada
| | - Maxime Descoteaux
- Sherbrooke Connectivity Imaging Laboratory (SCIL), Computer Science Department, Université de Sherbrooke, Sherbrooke, Québec, Canada
| | - Nikola Stikov
- NeuroPoly Lab, Polytechnique Montreal, Montreal, Québec, Canada
- Montreal Heart Institute, University of Montreal, Montreal, Québec, Canada
- Center for Advanced Interdisciplinary Research, Ss. Cyril and Methodius University, Skopje, North Macedonia
- NYUAD Research Institute, New York University Abu Dhabi, Abu Dhabi, UAE
| |
Collapse
|
3
|
Xu X, Sun C, Yu H, Yan G, Zhu Q, Kong X, Pan Y, Xu H, Zheng T, Zhou C, Wang Y, Xiao J, Chen R, Li M, Zhang S, Hu H, Zou Y, Wang J, Wang G, Wu D. Site effects in multisite fetal brain MRI: morphological insights into early brain development. Eur Radiol 2025; 35:1830-1842. [PMID: 39299951 DOI: 10.1007/s00330-024-11084-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2024] [Revised: 06/06/2024] [Accepted: 08/26/2024] [Indexed: 09/22/2024]
Abstract
OBJECTIVE To evaluate multisite effects on fetal brain MRI. Specifically, to identify crucial acquisition factors affecting fetal brain structural measurements and developmental patterns, while assessing the effectiveness of existing harmonization methods in mitigating site effects. MATERIALS AND METHODS Between May 2017 and March 2022, T2-weighted fast spin-echo sequences in-utero MRI were performed on healthy fetuses from retrospectively recruited pregnant volunteers on four different scanners at four sites. A generalized additive model (GAM) was used to quantitatively assess site effects, including field strength (FS), manufacturer (M), in-plane resolution (R), and slice thickness (ST), on subcortical volume and cortical morphological measurements, including cortical thickness, curvature, and sulcal depth. Growth models were selected to elucidate the developmental trajectories of these morphological measurements. Welch's test was performed to evaluate the influence of site effects on developmental trajectories. The comBat-GAM harmonization method was applied to mitigate site-related biases. RESULTS The final analytic sample consisted of 340 MRI scans from 218 fetuses (mean GA, 30.1 weeks ± 4.4 [range, 21.7-40 weeks]). GAM results showed that lower FS and lower spatial resolution led to overestimations in selected brain regions of subcortical volumes and cortical morphological measurements. Only the peak cortical thickness in developmental trajectories was significantly influenced by the effects of FS and R. Notably, ComBat-GAM harmonization effectively removed site effects while preserving developmental patterns. CONCLUSION Our findings pinpointed the key acquisition factors in in-utero fetal brain MRI and underscored the necessity of data harmonization when pooling multisite data for fetal brain morphology investigations. KEY POINTS Question How do specific site MRI acquisition factors affect fetal brain imaging? Finding Lower FS and spatial resolution overestimated subcortical volumes and cortical measurements. Cortical thickness in developmental trajectories was influenced by FS and in-plane resolution. Clinical relevance This study provides important guidelines for the fetal MRI community when scanning fetal brains and underscores the necessity of data harmonization of cross-center fetal studies.
Collapse
Affiliation(s)
- Xinyi Xu
- Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China
| | - Cong Sun
- Department of Radiology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China
| | - Hong Yu
- Dalian Municipal Women and Children's Medical Center (Group), Dalian, China
| | - Guohui Yan
- Department of Radiology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Qingqing Zhu
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Xianglei Kong
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Yibin Pan
- Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
- Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China
| | - Haoan Xu
- Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China
| | - Tianshu Zheng
- Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China
| | - Chi Zhou
- Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China
| | - Yutian Wang
- Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China
| | - Jiaxin Xiao
- Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China
- School of Biomedical Engineering & Imaging Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK
| | - Ruike Chen
- Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China
| | - Mingyang Li
- Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China
| | - Songying Zhang
- Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
- Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province, Zhejiang Provincial Clinical Research Center for Obstetrics and Gynecology, Hangzhou, China
| | - Hongjie Hu
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
| | - Yu Zou
- Department of Radiology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
| | - Jingshi Wang
- Dalian Municipal Women and Children's Medical Center (Group), Dalian, China.
| | - Guangbin Wang
- Department of Radiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
| | - Dan Wu
- Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China.
| |
Collapse
|
4
|
Khajetash B, Hajianfar G, Talebi A, Mahdavi SR, Ghavidel B, Kalati FA, Molana SH, Lei Y, Tavakoli M. Impact of harmonization on predicting complications in head and neck cancer after radiotherapy using MRI radiomics and machine learning techniques. Med Phys 2025. [PMID: 40162683 DOI: 10.1002/mp.17793] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2024] [Revised: 01/21/2025] [Accepted: 03/11/2025] [Indexed: 04/02/2025] Open
Abstract
BACKGROUND Variations in medical images specific to individual scanners restrict the use of radiomics in both clinical practice and research. To create reproducible and generalizable radiomics-based models for outcome prediction and assessment, data harmonization is essential. PURPOSE This study aims to investigate the impact of harmonization in performance of machine learning-based radiomics model toward the prediction of radiotherapy-induced toxicity (early and late sticky saliva and xerostomia) in head and neck cancer (HNC) patients after radiation therapy usingT 1 $T_1$ andT 2 $T_2$ -weighted magnetic resonance (MR) images. METHODS A total of 85 HNC patients who underwent radiotherapy was studied. Radiomic features were extracted fromT 1 $T_1$ andT 2 $T_2$ -weighted MR images with standardized protocols. Data harmonization was performed using ComBat algorithm to reduce inter-center variability. Besides imaging features, both dosimetric and demographic features were extracted and used in our model. Recursive feature elimination was employed as feature selection method to identify the most important variables. Ten classification algorithms, including eXtreme Gradient Boosting (XGBoost), multilayer perceptron (MLP), support vector machines (SVM), random forest (RF), k-nearest neighbor (KNN), Naive Bayes (NB), logistic regression (LR), and decision tree (DT), boosted generalized linear model (GLMB), and stack learning (SL) were utilized and compared to develop predictive models. This evaluation comparisons were performed before and after harmonization to demonstrate its significance. RESULTS Our results indicate that harmonization consistently enhances predictive performance across various complications and imaging modalities. In early and late sticky saliva prediction usingT 1 $T_1$ -weighted images, the SVM and RF models achieved an impressive area under the curve (AUC) of 0.88 ± $\pm$ 0.09 and 0.97 ± $\pm$ 0.05 with harmonization versus 0.42 ± $\pm$ 0.12 and 0.83 ± $\pm$ 0.08 without harmonization, respectively. Similarly, in early and late xerostomia prediction, the model attained an AUC of 0.79 ± $\pm$ 0.15 and 0.61 ± $\pm$ 0.14 with harmonization and 0.55 ± $\pm$ 0.17 and 0.46 ± $\pm$ 0.14 without harmonization. CONCLUSION Our study highlights the importance of harmonization techniques in improving the performance of predictive models utilizing magnetic resonance imaging radiomics features. While harmonization consistently enhanced performance for sticky saliva and early xerostomia usingT 1 $T_1$ -weighted features, the prediction of early and late xerostomia usingT 2 $T_2$ -weighted features remains challenging. These findings try to develop accurate and reliable predictive models in medical imaging, that contribute to improve patient care and treatment outcomes.
Collapse
Affiliation(s)
- Benyamin Khajetash
- Department of Medical physics, Iran University of Medical Sciences, Tehran, Iran
| | - Ghasem Hajianfar
- Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Science, Tehran, Iran
| | - Amin Talebi
- Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - Seid Rabi Mahdavi
- Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
- Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Beth Ghavidel
- Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
| | | | - Seyed Hadi Molana
- Department of Radiation Oncology, Roshana Cancer Institute, Tehran, Iran
| | - Yang Lei
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Meysam Tavakoli
- Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA
| |
Collapse
|
5
|
Dorfner FJ, Patel JB, Kalpathy-Cramer J, Gerstner ER, Bridge CP. A review of deep learning for brain tumor analysis in MRI. NPJ Precis Oncol 2025; 9:2. [PMID: 39753730 PMCID: PMC11698745 DOI: 10.1038/s41698-024-00789-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Accepted: 12/17/2024] [Indexed: 01/06/2025] Open
Abstract
Recent progress in deep learning (DL) is producing a new generation of tools across numerous clinical applications. Within the analysis of brain tumors in magnetic resonance imaging, DL finds applications in tumor segmentation, quantification, and classification. It facilitates objective and reproducible measurements crucial for diagnosis, treatment planning, and disease monitoring. Furthermore, it holds the potential to pave the way for personalized medicine through the prediction of tumor type, grade, genetic mutations, and patient survival outcomes. In this review, we explore the transformative potential of DL for brain tumor care and discuss existing applications, limitations, and future directions and opportunities.
Collapse
Affiliation(s)
- Felix J Dorfner
- Athinoula A. Martinos Center for Biomedical Imaging, 149 13th St, Charlestown, MA, 02129, USA
| | - Jay B Patel
- Athinoula A. Martinos Center for Biomedical Imaging, 149 13th St, Charlestown, MA, 02129, USA
| | | | - Elizabeth R Gerstner
- Athinoula A. Martinos Center for Biomedical Imaging, 149 13th St, Charlestown, MA, 02129, USA
- Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA
| | - Christopher P Bridge
- Athinoula A. Martinos Center for Biomedical Imaging, 149 13th St, Charlestown, MA, 02129, USA.
| |
Collapse
|
6
|
Archetti D, Venkatraghavan V, Weiss B, Bourgeat P, Auer T, Vidnyánszky Z, Durrleman S, van der Flier WM, Barkhof F, Alexander DC, Altmann A, Redolfi A, Tijms BM, Oxtoby NP. A Machine Learning Model to Harmonize Volumetric Brain MRI Data for Quantitative Neuroradiologic Assessment of Alzheimer Disease. Radiol Artif Intell 2025; 7:e240030. [PMID: 39692594 DOI: 10.1148/ryai.240030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2024]
Abstract
Purpose To extend a previously developed machine learning algorithm for harmonizing brain volumetric data of individuals undergoing neuroradiologic assessment of Alzheimer disease not encountered during model training. Materials and Methods Neuroharmony is a recently developed method that uses image quality metrics as predictors to remove scanner-related effects in brain-volumetric data using random forest regression. To account for the interactions between Alzheimer disease pathology and image quality metrics during harmonization, the authors developed a multiclass extension of Neuroharmony for individuals with and without cognitive impairment. Cross-validation experiments were performed to benchmark performance against other available strategies using data from 20 864 participants with and without cognitive impairment, spanning 11 prospective and retrospective cohorts and 43 scanners. Evaluation metrics assessed the ability to remove scanner-related variations in brain volumes (marker concordance between scanner pairs) while retaining the ability to delineate different diagnostic groups (preserving disease-related signal). Results For each strategy, marker concordances between scanners were significantly better (P < .001) compared with preharmonized data. The proposed multiclass model achieved significantly higher concordance (mean, 0.75 ± 0.09 [SD]) than the Neuroharmony model trained on individuals without cognitive impairment (mean, 0.70 ± 0.11) and preserved disease-related signal (∆AUC [area under the receiver operating characteristic curve] = -0.006 ± 0.027) better than the Neuroharmony model trained on individuals with and without cognitive impairment that did not use the proposed extension (∆AUC = -0.091 ± 0.036). The marker concordance was better in scanners seen during training (concordance > 0.97) than unseen (concordance < 0.79), independent of cognitive status. Conclusion In a large-scale multicenter dataset, the proposed multiclass Neuroharmony model outperformed other available strategies for harmonizing brain volumetric data from unseen scanners in a clinical setting. Keywords: Image Postprocessing, MR Imaging, Dementia, Random Forest Supplemental material is available for this article. Published under a CC BY 4.0 license See also commentary by Haller in this issue.
Collapse
Affiliation(s)
- Damiano Archetti
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Vikram Venkatraghavan
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Béla Weiss
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Pierrick Bourgeat
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Tibor Auer
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Zoltán Vidnyánszky
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Stanley Durrleman
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Wiesje M van der Flier
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Frederik Barkhof
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Daniel C Alexander
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Andre Altmann
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Alberto Redolfi
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Betty M Tijms
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| | - Neil P Oxtoby
- From the Laboratory of Neuroinformatics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni 4, Brescia 25125, Italy (D.A., A.R.); Alzheimer Centre Amsterdam, Neurology, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Amsterdam Neuroscience, Neurodegeneration, Amsterdam, the Netherlands (V.V., W.M.v.d.F., B.M.T.); Brain Imaging Centre, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary (B.W., T.A., Z.V.); Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Óbuda University, Budapest, Hungary (B.W.); The Australian e-Health Research Centre, CSIRO Health and Biosecurity, Brisbane, Australia (P.B.); School of Psychology, University of Surrey, Guildford, United Kingdom (T.A.); Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, CNRS, Inria, Inserm, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France (S.D.); Department of Epidemiology and Data Science, Vrije Universiteit, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands (W.M.v.d.F.); Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands (F.B.); Queen Square Institute of Neurology, University College London, United Kingdom (F.B.); and UCL Hawkes Institute, Department of Medical Physics and Biomedical Engineering and Department of Computer Science, University College London, London, United Kingdom (F.B., D.C.A., A.A., N.P.O.)
| |
Collapse
|
7
|
Roca V, Kuchcinski G, Pruvo JP, Manouvriez D, Lopes R. IGUANe: A 3D generalizable CycleGAN for multicenter harmonization of brain MR images. Med Image Anal 2025; 99:103388. [PMID: 39546981 DOI: 10.1016/j.media.2024.103388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2024] [Revised: 10/31/2024] [Accepted: 11/03/2024] [Indexed: 11/17/2024]
Abstract
In MRI studies, the aggregation of imaging data from multiple acquisition sites enhances sample size but may introduce site-related variabilities that hinder consistency in subsequent analyses. Deep learning methods for image translation have emerged as a solution for harmonizing MR images across sites. In this study, we introduce IGUANe (Image Generation with Unified Adversarial Networks), an original 3D model that leverages the strengths of domain translation and straightforward application of style transfer methods for multicenter brain MR image harmonization. IGUANe extends CycleGAN by integrating an arbitrary number of domains for training through a many-to-one architecture. The framework based on domain pairs enables the implementation of sampling strategies that prevent confusion between site-related and biological variabilities. During inference, the model can be applied to any image, even from an unknown acquisition site, making it a universal generator for harmonization. Trained on a dataset comprising T1-weighted images from 11 different scanners, IGUANe was evaluated on data from unseen sites. The assessments included the transformation of MR images with traveling subjects, the preservation of pairwise distances between MR images within domains, the evolution of volumetric patterns related to age and Alzheimer's disease (AD), and the performance in age regression and patient classification tasks. Comparisons with other harmonization and normalization methods suggest that IGUANe better preserves individual information in MR images and is more suitable for maintaining and reinforcing variabilities related to age and AD. Future studies may further assess IGUANe in other multicenter contexts, either using the same model or retraining it for applications to different image modalities. Codes and the trained IGUANe model are available at https://github.com/RocaVincent/iguane_harmonization.git.
Collapse
Affiliation(s)
- Vincent Roca
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France.
| | - Grégory Kuchcinski
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; CHU Lille, Département de Neuroradiologie, F-59000 Lille, France
| | - Jean-Pierre Pruvo
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; CHU Lille, Département de Neuroradiologie, F-59000 Lille, France
| | - Dorian Manouvriez
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France
| | - Renaud Lopes
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000 Lille, France; CHU Lille, Département de Médecine Nucléaire, F-59000 Lille, France
| |
Collapse
|
8
|
Jack CR, Arani A, Borowski BJ, Cash DM, Crawford K, Das SR, DeCarli C, Fletcher E, Fox NC, Gunter JL, Ittyerah R, Harvey DJ, Jahanshad N, Maillard P, Malone IB, Nir TM, Reid RI, Reyes DA, Schwarz CG, Senjem ML, Thomas DL, Thompson PM, Tosun D, Yushkevich PA, Ward CP, Weiner MW, Alzheimer's Disease Neuroimaging Initiative. Overview of ADNI MRI. Alzheimers Dement 2024; 20:7350-7360. [PMID: 39258539 PMCID: PMC11485416 DOI: 10.1002/alz.14166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Revised: 07/09/2024] [Accepted: 07/11/2024] [Indexed: 09/12/2024]
Abstract
The magnetic resonance imaging (MRI) Core has been operating since Alzheimer's Disease Neuroimaging Initiative's (ADNI) inception, providing 20 years of data including reliable, multi-platform standardized protocols, carefully curated image data, and quantitative measures provided by expert investigators. The overarching purposes of the MRI Core include: (1) optimizing and standardizing MRI acquisition methods, which have been adopted by many multicenter studies and trials worldwide and (2) providing curated images and numeric summary values from relevant MRI sequences/contrasts to the scientific community. Over time, ADNI MRI has become increasingly complex. To remain technically current, the ADNI MRI protocol has changed substantially over the past two decades. The ADNI 4 protocol contains nine different imaging types (e.g., three dimensional [3D] T1-weighted and fluid-attenuated inversion recovery [FLAIR]). Our view is that the ADNI MRI data are a greatly underutilized resource. The purpose of this paper is to educate the scientific community on ADNI MRI methods and content to promote greater awareness, accessibility, and use. HIGHLIGHTS: The MRI Core provides multi-platform standardized protocols, carefully curated image data, and quantitative analysis by expert groups. The ADNI MRI protocol has undergone major changes over the past two decades to remain technically current. As of April 25, 2024, the following numbers of image series are available: 17,141 3D T1w; 6877 FLAIR; 3140 T2/PD; 6623 GRE; 3237 dMRI; 2846 ASL; 2968 TF-fMRI; and 2861 HighResHippo (see Table 1 for abbreviations). As of April 25, 2024, the following numbers of quantitative analyses are available: FreeSurfer 10,997; BSI 6120; tensor based morphometry (TBM) and TBM-SYN 12,019; WMH 9944; dMRI 1913; ASL 925; TF-fMRI NFQ 2992; and medial temporal subregion volumes 2726 (see Table 4 for abbreviations). ADNI MRI is an underutilized resource that could be more useful to the research community.
Collapse
Affiliation(s)
| | - Arvin Arani
- Department of RadiologyMayo ClinicRochesterMinnesotaUSA
| | | | - Dave M. Cash
- Dementia Research CentreUniversity College London Institute of Neurology, Queen SquareLondonUK
| | - Karen Crawford
- Laboratory of Neuro Imaging (LONI)University of Southern CaliforniaLos AngelesCaliforniaUSA
| | - Sandhitsu R. Das
- Department of NeurologyUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Charles DeCarli
- Department of NeurologyUniversity of CaliforniaDavisCaliforniaUSA
| | - Evan Fletcher
- Department of NeurologyUniversity of CaliforniaDavisCaliforniaUSA
| | - Nick C. Fox
- Dementia Research CentreUniversity College London Institute of Neurology, Queen SquareLondonUK
| | | | - Ranjit Ittyerah
- Department of RadiologyUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | - Danielle J. Harvey
- Department of Public Health SciencesDivision of BiostatisticsUniversity of CaliforniaDavisCaliforniaUSA
| | | | - Pauline Maillard
- Department of NeurologyUniversity of CaliforniaDavisCaliforniaUSA
| | - Ian B. Malone
- Dementia Research CentreUniversity College London Institute of Neurology, Queen SquareLondonUK
| | - Talia M. Nir
- Keck School of Medicine of USCLos AngelesCaliforniaUSA
| | | | | | | | - Matthew L. Senjem
- Department of Information TechnologyMayo ClinicRochesterMinnesotaUSA
| | - David L. Thomas
- Department of Brain Repair and RehabilitationUCL Queen Square Institute of NeurologyLondonUK
| | - Paul M. Thompson
- Laboratory of Neuro Imaging (LONI)University of Southern CaliforniaLos AngelesCaliforniaUSA
| | - Duygu Tosun
- Department of Radiology and Biomedical ImagingUniversity of California, San FranciscoSan FranciscoCaliforniaUSA
| | - Paul A. Yushkevich
- Department of RadiologyUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA
| | | | - Michael W. Weiner
- Department of Radiology and Biomedical ImagingUniversity of California, San FranciscoSan FranciscoCaliforniaUSA
| | | |
Collapse
|
9
|
Patel J, Schöttner M, Tarun A, Tourbier S, Alemán-Gómez Y, Hagmann P, Bolton TAW. Modeling the impact of MRI acquisition bias on structural connectomes: Harmonizing structural connectomes. Netw Neurosci 2024; 8:623-652. [PMID: 39355442 PMCID: PMC11340995 DOI: 10.1162/netn_a_00368] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2023] [Accepted: 02/26/2024] [Indexed: 10/03/2024] Open
Abstract
One way to increase the statistical power and generalizability of neuroimaging studies is to collect data at multiple sites or merge multiple cohorts. However, this usually comes with site-related biases due to the heterogeneity of scanners and acquisition parameters, negatively impacting sensitivity. Brain structural connectomes are not an exception: Being derived from T1-weighted and diffusion-weighted magnetic resonance images, structural connectivity is impacted by differences in imaging protocol. Beyond minimizing acquisition parameter differences, removing bias with postprocessing is essential. In this work we create, from the exhaustive Human Connectome Project Young Adult dataset, a resampled dataset of different b-values and spatial resolutions, modeling a cohort scanned across multiple sites. After demonstrating the statistical impact of acquisition parameters on connectivity, we propose a linear regression with explicit modeling of b-value and spatial resolution, and validate its performance on separate datasets. We show that b-value and spatial resolution affect connectivity in different ways and that acquisition bias can be reduced using a linear regression informed by the acquisition parameters while retaining interindividual differences and hence boosting fingerprinting performance. We also demonstrate the generative potential of our model, and its generalization capability in an independent dataset reflective of typical acquisition practices in clinical settings.
Collapse
Affiliation(s)
- Jagruti Patel
- Department of Radiology, Lausanne University Hospital and University of Lausanne (CHUV-UNIL), Lausanne, Switzerland
| | - Mikkel Schöttner
- Department of Radiology, Lausanne University Hospital and University of Lausanne (CHUV-UNIL), Lausanne, Switzerland
| | - Anjali Tarun
- Department of Radiology, Lausanne University Hospital and University of Lausanne (CHUV-UNIL), Lausanne, Switzerland
| | - Sebastien Tourbier
- Department of Radiology, Lausanne University Hospital and University of Lausanne (CHUV-UNIL), Lausanne, Switzerland
| | - Yasser Alemán-Gómez
- Department of Radiology, Lausanne University Hospital and University of Lausanne (CHUV-UNIL), Lausanne, Switzerland
| | - Patric Hagmann
- Department of Radiology, Lausanne University Hospital and University of Lausanne (CHUV-UNIL), Lausanne, Switzerland
| | - Thomas A W Bolton
- Department of Radiology, Lausanne University Hospital and University of Lausanne (CHUV-UNIL), Lausanne, Switzerland
| |
Collapse
|
10
|
Xu C, Li J, Wang Y, Wang L, Wang Y, Zhang X, Liu W, Chen J, Vatian A, Gusarova N, Ye C, Zheng Z. SiMix: A domain generalization method for cross-site brain MRI harmonization via site mixing. Neuroimage 2024; 299:120812. [PMID: 39197559 DOI: 10.1016/j.neuroimage.2024.120812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2024] [Revised: 08/20/2024] [Accepted: 08/22/2024] [Indexed: 09/01/2024] Open
Abstract
Brain magnetic resonance imaging (MRI) is widely used in clinical practice for disease diagnosis. However, MRI scans acquired at different sites can have different appearances due to the difference in the hardware, pulse sequence, and imaging parameter. It is important to reduce or eliminate such cross-site variations with brain MRI harmonization so that downstream image processing and analysis is performed consistently. Previous works on the harmonization problem require the data acquired from the sites of interest for model training. But in real-world scenarios there can be test data from a new site of interest after the model is trained, and training data from the new site is unavailable when the model is trained. In this case, previous methods cannot optimally handle the test data from the new unseen site. To address the problem, in this work we explore domain generalization for brain MRI harmonization and propose Site Mix (SiMix). We assume that images of travelling subjects are acquired at a few existing sites for model training. To allow the training data to better represent the test data from unseen sites, we first propose to mix the training images belonging to different sites stochastically, which substantially increases the diversity of the training data while preserving the authenticity of the mixed training images. Second, at test time, when a test image from an unseen site is given, we propose a multiview strategy that perturbs the test image with preserved authenticity and ensembles the harmonization results of the perturbed images for improved harmonization quality. To validate SiMix, we performed experiments on the publicly available SRPBS dataset and MUSHAC dataset that comprised brain MRI acquired at nine and two different sites, respectively. The results indicate that SiMix improves brain MRI harmonization for unseen sites, and it is also beneficial to the harmonization of existing sites.
Collapse
Affiliation(s)
- Chundan Xu
- School of Integrated Circuits and Electronics, Beijing Institute of Technology, Beijing, China
| | - Jie Li
- Department of Radiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China
| | - Yakui Wang
- Department of Radiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China
| | - Lixue Wang
- Department of Radiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China
| | - Yizhe Wang
- Department of Radiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China
| | - Xiaofeng Zhang
- School of Information and Electronics, Beijing Institute of Technology, Zhuhai, China
| | - Weiqi Liu
- Sophmind Technology (Beijing) Co., Ltd., Beijing, China
| | - Jingang Chen
- Sophmind Technology (Beijing) Co., Ltd., Beijing, China
| | - Aleksandra Vatian
- Faculty of Infocommunicational Technologies, ITMO University, St. Petersburg, Russia
| | - Natalia Gusarova
- Faculty of Infocommunicational Technologies, ITMO University, St. Petersburg, Russia
| | - Chuyang Ye
- School of Integrated Circuits and Electronics, Beijing Institute of Technology, Beijing, China.
| | - Zhuozhao Zheng
- Department of Radiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
| |
Collapse
|
11
|
Gebre RK, Graff-Radford J, Ramanan VK, Raghavan S, Hofrenning EI, Przybelski SA, Nguyen AT, Lesnick TG, Gunter JL, Algeciras-Schimnich A, Knopman DS, Machulda MM, Vassilaki M, Lowe VJ, Jack CR, Petersen RC, Vemuri P. Can integration of Alzheimer's plasma biomarkers with MRI, cardiovascular, genetics, and lifestyle measures improve cognition prediction? Brain Commun 2024; 6:fcae300. [PMID: 39291164 PMCID: PMC11406552 DOI: 10.1093/braincomms/fcae300] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2024] [Revised: 07/13/2024] [Accepted: 09/03/2024] [Indexed: 09/19/2024] Open
Abstract
There is increasing interest in Alzheimer's disease related plasma biomarkers due to their accessibility and scalability. We hypothesized that integrating plasma biomarkers with other commonly used and available participant data (MRI, cardiovascular factors, lifestyle, genetics) using machine learning (ML) models can improve individual prediction of cognitive outcomes. Further, our goal was to evaluate the heterogeneity of these predictors across different age strata. This longitudinal study included 1185 participants from the Mayo Clinic Study of Aging who had complete plasma analyte work-up at baseline. We used the Quanterix Simoa immunoassay to measure neurofilament light, Aβ1-42 and Aβ1-40 (used as Aβ42/Aβ40 ratio), glial fibrillary acidic protein, and phosphorylated tau 181 (p-tau181). Participants' brain health was evaluated through gray and white matter structural MRIs. The study also considered cardiovascular factors (hyperlipidemia, hypertension, stroke, diabetes, chronic kidney disease), lifestyle factors (area deprivation index, body mass index, cognitive and physical activities), and genetic factors (APOE, single nucleotide polymorphisms, and polygenic risk scores). An ML model was developed to predict cognitive outcomes at baseline and decline (slope). Three models were created: a base model with groups of risk factors as predictors, an enhanced model included socio-demographics, and a final enhanced model by incorporating plasma and socio-demographics into the base models. Models were explained for three age strata: younger than 65 years, 65-80 years, and older than 80 years, and further divided based on amyloid positivity status. Regardless of amyloid status the plasma biomarkers showed comparable performance (R² = 0.15) to MRI (R² = 0.18) and cardiovascular measures (R² = 0.10) when predicting cognitive decline. Inclusion of cardiovascular or MRI measures with plasma in the presence of socio-demographic improved cognitive decline prediction (R² = 0.26 and 0.27). For amyloid positive individuals Aβ42/Aβ40, glial fibrillary acidic protein and p-tau181 were the top predictors of cognitive decline while Aβ42/Aβ40 was prominent for amyloid negative participants across all age groups. Socio-demographics explained a large portion of the variance in the amyloid negative individuals while the plasma biomarkers predominantly explained the variance in amyloid positive individuals (21% to 37% from the younger to the older age group). Plasma biomarkers performed similarly to MRI and cardiovascular measures when predicting cognitive outcomes and combining them with either measure resulted in better performance. Top predictors were heterogeneous between cross-sectional and longitudinal cognition models, across age groups, and amyloid status. Multimodal approaches will enhance the usefulness of plasma biomarkers through careful considerations of a study population's socio-demographics, brain and cardiovascular health.
Collapse
Affiliation(s)
- Robel K Gebre
- Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
| | | | - Vijay K Ramanan
- Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
| | | | | | - Scott A Przybelski
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA
| | - Aivi T Nguyen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
| | - Timothy G Lesnick
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA
| | | | | | - David S Knopman
- Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA
| | - Mary M Machulda
- Department of Psychology, Mayo Clinic, Rochester, MN 55905, USA
| | - Maria Vassilaki
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA
| | - Val J Lowe
- Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
| | - Clifford R Jack
- Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
| | | | | |
Collapse
|
12
|
Gardner M, Shinohara RT, Bethlehem RAI, Romero-Garcia R, Warrier V, Dorfschmidt L, Shanmugan S, Thompson P, Seidlitz J, Alexander-Bloch AF, Chen AA. ComBatLS: A location- and scale-preserving method for multi-site image harmonization. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.06.21.599875. [PMID: 39131292 PMCID: PMC11312440 DOI: 10.1101/2024.06.21.599875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/13/2024]
Abstract
Recent work has leveraged massive datasets and advanced harmonization methods to construct normative models of neuroanatomical features and benchmark individuals' morphology. However, current harmonization tools do not preserve the effects of biological covariates including sex and age on features' variances; this failure may induce error in normative scores, particularly when such factors are distributed unequally across sites. Here, we introduce a new extension of the popular ComBat harmonization method, ComBatLS, that preserves biological variance in features' locations and scales. We use UK Biobank data to show that ComBatLS robustly replicates individuals' normative scores better than other ComBat methods when subjects are assigned to sex-imbalanced synthetic "sites". Additionally, we demonstrate that ComBatLS significantly reduces sex biases in normative scores compared to traditional methods. Finally, we show that ComBatLS successfully harmonizes consortium data collected across over 50 studies. R implementation of ComBatLS is available at https://github.com/andy1764/ComBatFamily.
Collapse
Affiliation(s)
- Margaret Gardner
- Brain-Gene-Development Lab, The Children's Hospital of Philadelphia and Penn Medicine, Philadelphia, PA, USA
- Neuroscience Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Russell T Shinohara
- Penn Statistics in Imaging and Visualization Center, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA
- Center for Biomedical Imaging Computing and Analytics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, USA
| | | | - Rafael Romero-Garcia
- Instituto de Biomedicina de Sevilla (IBiS) HUVR/CSIC/Universidad de Sevilla/CIBERSAM, ISCIII, Dpto. de Fisiología Médica y Biofísica, Seville, ES
- Department of Psychiatry, University of Cambridge, Cambridge, UK
| | - Varun Warrier
- Department of Psychology, University of Cambridge, Cambridge, UK
- Department of Psychiatry, University of Cambridge, Cambridge, UK
| | - Lena Dorfschmidt
- Brain-Gene-Development Lab, The Children's Hospital of Philadelphia and Penn Medicine, Philadelphia, PA, USA
- Lifespan Brain Institute, The Children's Hospital of Philadelphia and Penn Medicine, Philadelphia, PA, USA
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - Sheila Shanmugan
- Lifespan Brain Institute, The Children's Hospital of Philadelphia and Penn Medicine, Philadelphia, PA, USA
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
- Penn Lifespan Informatics and Neuroimaging Center, University of Pennsylvania, Philadelphia, PA
| | - Paul Thompson
- Imaging Genetics Center, Stevens Institute for Neuroimaging & Informatics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | - Jakob Seidlitz
- Brain-Gene-Development Lab, The Children's Hospital of Philadelphia and Penn Medicine, Philadelphia, PA, USA
- Lifespan Brain Institute, The Children's Hospital of Philadelphia and Penn Medicine, Philadelphia, PA, USA
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
- Department of Child and Adolescent Psychiatry and Behavioral Science, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
| | - Aaron F Alexander-Bloch
- Brain-Gene-Development Lab, The Children's Hospital of Philadelphia and Penn Medicine, Philadelphia, PA, USA
- Lifespan Brain Institute, The Children's Hospital of Philadelphia and Penn Medicine, Philadelphia, PA, USA
- Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
- Department of Child and Adolescent Psychiatry and Behavioral Science, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
| | - Andrew A Chen
- Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA
| |
Collapse
|
13
|
Xu H, Newlin NR, Kim ME, Gao C, Kanakaraj P, Krishnan AR, Remedios LW, Khairi NM, Pechman K, Archer D, Hohman TJ, Jefferson AL, Isgum I, Huo Y, Moyer D, Schilling KG, Landman BA. Evaluation of Mean Shift, ComBat, and CycleGAN for Harmonizing Brain Connectivity Matrices Across Sites. PROCEEDINGS OF SPIE--THE INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING 2024; 12926:129261X. [PMID: 39310215 PMCID: PMC11415266 DOI: 10.1117/12.3005563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 09/25/2024]
Abstract
Connectivity matrices derived from diffusion MRI (dMRI) provide an interpretable and generalizable way of understanding the human brain connectome. However, dMRI suffers from inter-site and between-scanner variation, which impedes analysis across datasets to improve robustness and reproducibility of results. To evaluate different harmonization approaches on connectivity matrices, we compared graph measures derived from these matrices before and after applying three harmonization techniques: mean shift, ComBat, and CycleGAN. The sample comprises 168 age-matched, sex-matched normal subjects from two studies: the Vanderbilt Memory and Aging Project (VMAP) and the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD). First, we plotted the graph measures and used coefficient of variation (CoV) and the Mann-Whitney U test to evaluate different methods' effectiveness in removing site effects on the matrices and the derived graph measures. ComBat effectively eliminated site effects for global efficiency and modularity and outperformed the other two methods. However, all methods exhibited poor performance when harmonizing average betweenness centrality. Second, we tested whether our harmonization methods preserved correlations between age and graph measures. All methods except for CycleGAN in one direction improved correlations between age and global efficiency and between age and modularity from insignificant to significant with p-values less than 0.05.
Collapse
Affiliation(s)
- Hanliang Xu
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
| | - Nancy R Newlin
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
| | - Michael E Kim
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
| | - Chenyu Gao
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
| | | | - Aravind R Krishnan
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
| | - Lucas W Remedios
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
| | - Nazirah Mohd Khairi
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
| | - Kimberly Pechman
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Derek Archer
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA
- Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, TN, USA
| | - Timothy J Hohman
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA
- Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, TN, USA
| | - Angela L Jefferson
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Ivana Isgum
- Department of Biomedical Engineering and Physics & Radiology and Nuclear Medicine, University Medical Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands
| | - Yuankai Huo
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
| | - Daniel Moyer
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
| | - Kurt G Schilling
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
- Vanderbilt University Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA
| | - Bennett A Landman
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA
- Vanderbilt University Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA
- Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA
| |
Collapse
|
14
|
Xu H, Newlin NR, Kim ME, Gao C, Kanakaraj P, Krishnan AR, Remedios LW, Khairi NM, Pechman K, Archer D, Hohman TJ, Jefferson AL, Isgum I, Huo Y, Moyer D, Schilling KG, Landman BA. Evaluation of Mean Shift, ComBat, and CycleGAN for Harmonizing Brain Connectivity Matrices Across Sites. ARXIV 2024:arXiv:2401.06798v2. [PMID: 38344221 PMCID: PMC10854272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Figures] [Subscribe] [Scholar Register] [Indexed: 02/17/2024]
Abstract
Connectivity matrices derived from diffusion MRI (dMRI) provide an interpretable and generalizable way of understanding the human brain connectome. However, dMRI suffers from inter-site and between-scanner variation, which impedes analysis across datasets to improve robustness and reproducibility of results. To evaluate different harmonization approaches on connectivity matrices, we compared graph measures derived from these matrices before and after applying three harmonization techniques: mean shift, ComBat, and CycleGAN. The sample comprises 168 age-matched, sex-matched normal subjects from two studies: the Vanderbilt Memory and Aging Project (VMAP) and the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD). First, we plotted the graph measures and used coefficient of variation (CoV) and the Mann-Whitney U test to evaluate different methods' effectiveness in removing site effects on the matrices and the derived graph measures. ComBat effectively eliminated site effects for global efficiency and modularity and outperformed the other two methods. However, all methods exhibited poor performance when harmonizing average betweenness centrality. Second, we tested whether our harmonization methods preserved correlations between age and graph measures. All methods except for CycleGAN in one direction improved correlations between age and global efficiency and between age and modularity from insignificant to significant with p-values less than 0.05.
Collapse
Affiliation(s)
- Hanliang Xu
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
| | - Nancy R Newlin
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
| | - Michael E Kim
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
| | - Chenyu Gao
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
| | | | - Aravind R Krishnan
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
| | - Lucas W Remedios
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
| | - Nazirah Mohd Khairi
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
| | - Kimberly Pechman
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Derek Archer
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA
- Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, TN, USA
| | - Timothy J Hohman
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA
- Vanderbilt Genetics Institute, Vanderbilt University School of Medicine, Nashville, TN, USA
| | - Angela L Jefferson
- Vanderbilt Memory and Alzheimer's Center, Vanderbilt University Medical Center, Nashville, TN, USA
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA
- Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Ivana Isgum
- Department of Biomedical Engineering and Physics & Radiology and Nuclear Medicine, University Medical Center Amsterdam, University of Amsterdam, Amsterdam, the Netherlands
| | - Yuankai Huo
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
| | - Daniel Moyer
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
| | - Kurt G Schilling
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
- Vanderbilt University Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA
| | - Bennett A Landman
- Department of Computer Science, Vanderbilt University, Nashville, TN, USA
- Department of Electrical and Computer Engineering, Vanderbilt University, Nashville, TN, USA
- Department of Neurology, Vanderbilt University Medical Center, Nashville, TN, USA
- Vanderbilt University Institute of Imaging Science, Vanderbilt University, Nashville, TN, USA
- Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA
| |
Collapse
|
15
|
Roca V, Kuchcinski G, Pruvo JP, Manouvriez D, Leclerc X, Lopes R. A three-dimensional deep learning model for inter-site harmonization of structural MR images of the brain: Extensive validation with a multicenter dataset. Heliyon 2023; 9:e22647. [PMID: 38107313 PMCID: PMC10724680 DOI: 10.1016/j.heliyon.2023.e22647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Revised: 10/03/2023] [Accepted: 11/15/2023] [Indexed: 12/19/2023] Open
Abstract
In multicenter MRI studies, pooling the imaging data can introduce site-related variabilities and can therefore bias the subsequent analyses. To harmonize the intensity distributions of brain MR images in a multicenter dataset, unsupervised deep learning methods can be employed. Here, we developed a model based on cycle-consistent adversarial networks for the harmonization of T1-weighted brain MR images. In contrast to previous works, it was designed to process three-dimensional whole-brain images in a stable manner while optimizing computation resources. Using six different MRI datasets for healthy adults (n=1525 in total) with different acquisition parameters, we tested the model in (i) three pairwise harmonizations with site effects of various sizes, (ii) an overall harmonization of the six datasets with different age distributions, and (iii) a traveling-subject dataset. Our results for intensity distributions, brain volumes, image quality metrics and radiomic features indicated that the MRI characteristics at the various sites had been effectively homogenized. Next, brain age prediction experiments and the observed correlation between the gray-matter volume and age showed that thanks to an appropriate training strategy and despite biological differences between the dataset populations, the model reinforced biological patterns. Furthermore, radiologic analyses of the harmonized images attested to the conservation of the radiologic information in the original images. The robustness of the harmonization model (as judged with various datasets and metrics) demonstrates its potential for application in retrospective multicenter studies.
Collapse
Affiliation(s)
- Vincent Roca
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France
| | - Grégory Kuchcinski
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France
- Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neurosciences & Cognition, F-59000 Lille, France
- CHU Lille, Department of Neuroradiology, F-59000 Lille, France
| | - Jean-Pierre Pruvo
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France
- Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neurosciences & Cognition, F-59000 Lille, France
- CHU Lille, Department of Neuroradiology, F-59000 Lille, France
| | - Dorian Manouvriez
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France
| | - Xavier Leclerc
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France
- Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neurosciences & Cognition, F-59000 Lille, France
- CHU Lille, Department of Neuroradiology, F-59000 Lille, France
| | - Renaud Lopes
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, F-59000 Lille, France
- Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neurosciences & Cognition, F-59000 Lille, France
| |
Collapse
|
16
|
Kushol R, Parnianpour P, Wilman AH, Kalra S, Yang YH. Effects of MRI scanner manufacturers in classification tasks with deep learning models. Sci Rep 2023; 13:16791. [PMID: 37798392 PMCID: PMC10556074 DOI: 10.1038/s41598-023-43715-5] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Accepted: 09/27/2023] [Indexed: 10/07/2023] Open
Abstract
Deep learning has become a leading subset of machine learning and has been successfully employed in diverse areas, ranging from natural language processing to medical image analysis. In medical imaging, researchers have progressively turned towards multi-center neuroimaging studies to address complex questions in neuroscience, leveraging larger sample sizes and aiming to enhance the accuracy of deep learning models. However, variations in image pixel/voxel characteristics can arise between centers due to factors including differences in magnetic resonance imaging scanners. Such variations create challenges, particularly inconsistent performance in machine learning-based approaches, often referred to as domain shift, where the trained models fail to achieve satisfactory or improved results when confronted with dissimilar test data. This study analyzes the performance of multiple disease classification tasks using multi-center MRI data obtained from three widely used scanner manufacturers (GE, Philips, and Siemens) across several deep learning-based networks. Furthermore, we investigate the efficacy of mitigating scanner vendor effects using ComBat-based harmonization techniques when applied to multi-center datasets of 3D structural MR images. Our experimental results reveal a substantial decline in classification performance when models trained on one type of scanner manufacturer are tested with data from different manufacturers. Moreover, despite applying ComBat-based harmonization, the harmonized images do not demonstrate any noticeable performance enhancement for disease classification tasks.
Collapse
Affiliation(s)
- Rafsanjany Kushol
- Department of Computing Science, University of Alberta, Edmonton, Canada.
| | - Pedram Parnianpour
- Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada
| | - Alan H Wilman
- Departments of Radiology and Diagnostic Imaging and Biomedical Engineering, University of Alberta, Edmonton, Canada
| | - Sanjay Kalra
- Department of Computing Science, University of Alberta, Edmonton, Canada
- Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada
- Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Canada
| | - Yee-Hong Yang
- Department of Computing Science, University of Alberta, Edmonton, Canada
| |
Collapse
|
17
|
Zuo L, Liu Y, Xue Y, Dewey BE, Remedios SW, Hays SP, Bilgel M, Mowry EM, Newsome SD, Calabresi PA, Resnick SM, Prince JL, Carass A. HACA3: A unified approach for multi-site MR image harmonization. Comput Med Imaging Graph 2023; 109:102285. [PMID: 37657151 PMCID: PMC10592042 DOI: 10.1016/j.compmedimag.2023.102285] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Revised: 07/11/2023] [Accepted: 08/08/2023] [Indexed: 09/03/2023]
Abstract
The lack of standardization and consistency of acquisition is a prominent issue in magnetic resonance (MR) imaging. This often causes undesired contrast variations in the acquired images due to differences in hardware and acquisition parameters. In recent years, image synthesis-based MR harmonization with disentanglement has been proposed to compensate for the undesired contrast variations. The general idea is to disentangle anatomy and contrast information from MR images to achieve cross-site harmonization. Despite the success of existing methods, we argue that major improvements can be made from three aspects. First, most existing methods are built upon the assumption that multi-contrast MR images of the same subject share the same anatomy. This assumption is questionable, since different MR contrasts are specialized to highlight different anatomical features. Second, these methods often require a fixed set of MR contrasts for training (e.g., both T1-weighted and T2-weighted images), limiting their applicability. Lastly, existing methods are generally sensitive to imaging artifacts. In this paper, we present Harmonization with Attention-based Contrast, Anatomy, and Artifact Awareness (HACA3), a novel approach to address these three issues. HACA3 incorporates an anatomy fusion module that accounts for the inherent anatomical differences between MR contrasts. Furthermore, HACA3 can be trained and applied to any combination of MR contrasts and is robust to imaging artifacts. HACA3 is developed and evaluated on diverse MR datasets acquired from 21 sites with varying field strengths, scanner platforms, and acquisition protocols. Experiments show that HACA3 achieves state-of-the-art harmonization performance under multiple image quality metrics. We also demonstrate the versatility and potential clinical impact of HACA3 on downstream tasks including white matter lesion segmentation for people with multiple sclerosis and longitudinal volumetric analyses for normal aging subjects. Code is available at https://github.com/lianruizuo/haca3.
Collapse
Affiliation(s)
- Lianrui Zuo
- Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD 21218, USA; Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
| | - Yihao Liu
- Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD 21218, USA
| | - Yuan Xue
- Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD 21218, USA
| | - Blake E Dewey
- Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
| | - Samuel W Remedios
- Department of Computer Science, Johns Hopkins University, Baltimore, MD 21218, USA; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA
| | - Savannah P Hays
- Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD 21218, USA
| | - Murat Bilgel
- Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
| | - Ellen M Mowry
- Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
| | - Scott D Newsome
- Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
| | - Peter A Calabresi
- Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
| | - Susan M Resnick
- Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
| | - Jerry L Prince
- Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD 21218, USA
| | - Aaron Carass
- Department of Electrical and Computer Engineering, Johns Hopkins University, Baltimore, MD 21218, USA
| |
Collapse
|
18
|
Kushol R, Wilman AH, Kalra S, Yang YH. DSMRI: Domain Shift Analyzer for Multi-Center MRI Datasets. Diagnostics (Basel) 2023; 13:2947. [PMID: 37761314 PMCID: PMC10527875 DOI: 10.3390/diagnostics13182947] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 09/05/2023] [Accepted: 09/12/2023] [Indexed: 09/29/2023] Open
Abstract
In medical research and clinical applications, the utilization of MRI datasets from multiple centers has become increasingly prevalent. However, inherent variability between these centers presents challenges due to domain shift, which can impact the quality and reliability of the analysis. Regrettably, the absence of adequate tools for domain shift analysis hinders the development and validation of domain adaptation and harmonization techniques. To address this issue, this paper presents a novel Domain Shift analyzer for MRI (DSMRI) framework designed explicitly for domain shift analysis in multi-center MRI datasets. The proposed model assesses the degree of domain shift within an MRI dataset by leveraging various MRI-quality-related metrics derived from the spatial domain. DSMRI also incorporates features from the frequency domain to capture low- and high-frequency information about the image. It further includes the wavelet domain features by effectively measuring the sparsity and energy present in the wavelet coefficients. Furthermore, DSMRI introduces several texture features, thereby enhancing the robustness of the domain shift analysis process. The proposed framework includes visualization techniques such as t-SNE and UMAP to demonstrate that similar data are grouped closely while dissimilar data are in separate clusters. Additionally, quantitative analysis is used to measure the domain shift distance, domain classification accuracy, and the ranking of significant features. The effectiveness of the proposed approach is demonstrated using experimental evaluations on seven large-scale multi-site neuroimaging datasets.
Collapse
Affiliation(s)
- Rafsanjany Kushol
- Department of Computing Science, University of Alberta, Edmonton, AB T6G 2R3, Canada
| | - Alan H. Wilman
- Departments of Radiology and Diagnostic Imaging and Biomedical Engineering, University of Alberta, Edmonton, AB T6G 2R3, Canada
| | - Sanjay Kalra
- Department of Computing Science, University of Alberta, Edmonton, AB T6G 2R3, Canada
- Division of Neurology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada
| | - Yee-Hong Yang
- Department of Computing Science, University of Alberta, Edmonton, AB T6G 2R3, Canada
| |
Collapse
|
19
|
de Matos K, Cury C, Chougar L, Strike LT, Rolland T, Riche M, Hemforth L, Martin A, Banaschewski T, Bokde ALW, Desrivières S, Flor H, Grigis A, Garavan H, Gowland P, Heinz A, Brühl R, Martinot JL, Paillère Martinot ML, Artiges E, Nees F, Papadopoulos Orfanos D, Lemaitre H, Paus T, Poustka L, Hohmann S, Millenet S, Fröhner JH, Smolka MN, Vaidya N, Walter H, Whelan R, Schumann G, Frouin V, Bach Cuadra M, Colliot O, Couvy-Duchesne B. Temporo-basal sulcal connections: a manual annotation protocol and an investigation of sexual dimorphism and heritability. Brain Struct Funct 2023; 228:1459-1478. [PMID: 37358662 DOI: 10.1007/s00429-023-02663-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Accepted: 06/07/2023] [Indexed: 06/27/2023]
Abstract
The temporo-basal region of the human brain is composed of the collateral, the occipito-temporal, and the rhinal sulci. We manually rated (using a novel protocol) the connections between rhinal/collateral (RS-CS), collateral/occipito-temporal (CS-OTS) and rhinal/occipito-temporal (RS-OTS) sulci, using the MRI of nearly 3400 individuals including around 1000 twins. We reported both the associations between sulcal polymorphisms as well with a wide range of demographics (e.g. age, sex, handedness). Finally, we also estimated the heritability, and the genetic correlation between sulcal connections. We reported the frequency of the sulcal connections in the general population, which were hemisphere dependent. We found a sexual dimorphism of the connections, especially marked in the right hemisphere, with a CS-OTS connection more frequent in females (approximately 35-40% versus 20-25% in males) and an RS-CS connection more common in males (approximately 40-45% versus 25-30% in females). We confirmed associations between sulcal connections and characteristics of incomplete hippocampal inversion (IHI). We estimated the broad sense heritability to be 0.28-0.45 for RS-CS and CS-OTS connections, with hints of dominant contribution for the RS-CS connection. The connections appeared to share some of their genetic causing factors as indicated by strong genetic correlations. Heritability appeared much smaller for the (rarer) RS-OTS connection.
Collapse
Affiliation(s)
- Kevin de Matos
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France
- CIBM Center for Biomedical Imaging, Vaud, Switzerland
- Radiology Department, Lausanne University and University Hospital, Lausanne, Switzerland
| | - Claire Cury
- CNRS, Inria, Inserm, IRISA UMR 6074, Empenn ERL U-1228, University of Rennes, 35000, Rennes, France
| | - Lydia Chougar
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France
- Service de neuroradiologie, AP-HP, Pitié-Salpêtrière, Paris, France
| | - Lachlan T Strike
- Queensland Brain Institute, The University of Queensland, St Lucia, QLD, 4072, Australia
- Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - Thibault Rolland
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France
| | - Maximilien Riche
- Department of Neurosurgery, AP-HP, La Pitié-Salpêtrière Hospital, Sorbonne University, 75013, Paris, France
| | - Lisa Hemforth
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France
| | - Alexandre Martin
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France
- Inria Sophia Antipolis, Morpheme Project, Paris, France
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Square J5, 68159, Mannheim, Germany
| | - Arun L W Bokde
- Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland
| | - Sylvane Desrivières
- Centre for Population Neuroscience and Precision Medicine (PONS), Institute of Psychiatry, Psychology & Neuroscience, SGDP Centre, King's College London, London, UK
| | - Herta Flor
- Institute of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Square J5, Mannheim, Germany
- Department of Psychology, School of Social Sciences, University of Mannheim, 68131, Mannheim, Germany
| | - Antoine Grigis
- NeuroSpin, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France
| | - Hugh Garavan
- Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, 05405, USA
| | - Penny Gowland
- Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, UK
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, Berlin Institute of Health, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Rüdiger Brühl
- Physikalisch-Technische Bundesanstalt (PTB), Brunswick, Berlin, Germany
| | - Jean-Luc Martinot
- INSERM U 1299 "Trajectoires développementales & psychiatrie", CNRS, Institut National de la Santé et de la Recherche Médicale, Ecole Normale Supérieure Paris-Saclay, Centre Borelli, University Paris-Saclay, Gif-sur-Yvette, France
| | - Marie-Laure Paillère Martinot
- INSERM U 1299 "Trajectoires développementales & psychiatrie", CNRS, AP-HP, Institut National de la Santé et de la Recherche Médicale, Ecole Normale Supérieure Paris-Saclay, Centre Borelli, University Paris-Saclay, Gif-sur-Yvette, France
- Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France
| | - Eric Artiges
- INSERM U 1299 "Trajectoires développementales & psychiatrie", CNRS, Institut National de la Santé et de la Recherche Médicale, Ecole Normale Supérieure Paris-Saclay, Centre Borelli, University Paris-Saclay, Gif-sur-Yvette, France
- Psychiatry Department, EPS Barthélémy Durand, Etampes, France
| | - Frauke Nees
- Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Square J5, 68159, Mannheim, Germany
- Institute of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Square J5, Mannheim, Germany
- Institute of Medical Psychology and Medical Sociology, University Medical Center Schleswig Holstein, Kiel University, Kiel, Germany
| | | | - Herve Lemaitre
- NeuroSpin, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France
- UMR 5293, CNRS, CEA, Institut des Maladies Neurodégénératives, Université de Bordeaux, 33076, Bordeaux, France
| | - Tomáš Paus
- Departments of Psychiatry and Neuroscience, Université de Montréal and Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada
- Departments of Psychiatry and Psychology, University of Toronto, Toronto, ON, Canada
| | - Luise Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, Von-Siebold-Str. 5, 37075, Göttingen, Germany
| | - Sarah Hohmann
- Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Square J5, 68159, Mannheim, Germany
| | - Sabina Millenet
- Department of Child and Adolescent Psychiatry and Psychotherapy, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Square J5, 68159, Mannheim, Germany
| | - Juliane H Fröhner
- Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany
| | - Michael N Smolka
- Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany
| | - Nilakshi Vaidya
- Department of Psychiatry and Neuroscience, Centre for Population Neuroscience and Stratified Medicine (PONS), Charité Universitätsmedizin Berlin, Berlin, Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, Berlin Institute of Health, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany
| | - Robert Whelan
- School of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland
| | - Gunter Schumann
- Department of Psychiatry and Neuroscience, Centre for Population Neuroscience and Stratified Medicine (PONS), Charité Universitätsmedizin Berlin, Berlin, Germany
- Centre for Population Neuroscience and Precision Medicine (PONS), Institute for Science and Technology of Brain-Inspired Intelligence (ISTBI), Fudan University, Shanghai, China
| | - Vincent Frouin
- NeuroSpin, CEA, Université Paris-Saclay, 91191, Gif-sur-Yvette, France
| | - Meritxell Bach Cuadra
- CIBM Center for Biomedical Imaging, Vaud, Switzerland
- Radiology Department, Lausanne University and University Hospital, Lausanne, Switzerland
| | - Olivier Colliot
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France
| | - Baptiste Couvy-Duchesne
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, CNRS, Inria, Inserm, AP-HP, Hôpital de la Pitié Salpêtrière, 75013, Paris, France.
- Institute for Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4062, Australia.
- ARAMIS Team, Pitié-Salpêtrière Hospital, Institut du Cerveau, 75013, Paris, France.
| |
Collapse
|